Viberzi

Chemical Nameeluxadoline
Dosage FormTablet (oral; 75 mg, 100 mg)
Drug Classmu-opioid receptor agonist
SystemDigestive
CompanyAllergan
Approval Year2015

Indication

  • For treatment of adults with irritable bowel syndrome with diarrhea (IBS-D).
Document TitleYearSource
Viberzi (eluxadoline) Prescribing Information.2020Allergan USA, Inc., Madison, NJ
Drug updated on 6/12/2023

More on this drug: Clinical Trials